Pure Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.41M | Buy |
7,010
+2,026
| +41% | +$2.07M | 0.11% | 90 |
|
|
2026
Q1 | $4.58M | Buy |
4,984
+515
| +12% | +$522K | 0.07% | 117 |
|
|
2025
Q4 | $4.8M | Buy |
4,469
+149
| +3% | +$142K | 0.07% | 112 |
|
|
2025
Q3 | $3.3M | Sell |
4,320
-194
| -4% | -$144K | 0.05% | 129 |
|
|
2025
Q2 | $3.52M | Buy |
4,514
+641
| +17% | +$498K | 0.06% | 123 |
|
|
2025
Q1 | $3.2M | Buy |
3,873
+466
| +14% | +$388K | 0.07% | 105 |
|
|
2024
Q4 | $2.63M | Buy |
3,407
+1,058
| +45% | +$876K | 0.06% | 101 |
|
|
2024
Q3 | $2.08M | Sell |
2,349
-2,935
| -56% | -$2.64M | 0.05% | 115 |
|
|
2024
Q2 | $4.78M | Sell |
5,284
-115
| -2% | -$92K | 0.13% | 73 |
|
|
2024
Q1 | $4.2M | Buy |
5,399
+1,027
| +23% | +$731K | 0.13% | 77 |
|
|
2023
Q4 | $2.55M | Sell |
4,372
-130
| -3% | -$75.9K | 0.09% | 99 |
|
|
2023
Q3 | $2.42M | Buy |
4,502
+734
| +19% | +$378K | 0.1% | 90 |
|
|
2023
Q2 | $1.77M | Sell |
3,768
-11
| -0.3% | -$4.61K | 0.08% | 99 |
|
|
2023
Q1 | $1.3M | Sell |
3,779
-222
| -6% | -$74.9K | 0.06% | 108 |
|
|
2022
Q4 | $1.46M | Buy |
4,001
+44
| +1% | +$15.6K | 0.08% | 100 |
|
|
2022
Q3 | $1.28M | Buy |
3,957
+184
| +5% | +$58.3K | 0.07% | 98 |
|
|
2022
Q2 | $1.22M | Buy |
3,773
+696
| +23% | +$209K | 0.08% | 105 |
|
|
2022
Q1 | $881K | Buy |
3,077
+247
| +9% | +$63.6K | 0.04% | 114 |
|
|
2021
Q4 | $782K | Buy |
2,830
+56
| +2% | +$14.2K | 0.04% | 109 |
|
|
2021
Q3 | $641K | Buy |
2,774
+262
| +10% | +$64.7K | 0.05% | 116 |
|
|
2021
Q2 | $577K | Hold |
2,512
| – | – | 0.05% | 127 |
|
|
2021
Q1 | $469K | Hold |
2,512
| – | – | 0.05% | 123 |
|
|
2020
Q4 | $424K | Hold |
2,512
| – | – | 0.05% | 124 |
|
|
2020
Q3 | $372K | Hold |
2,512
| – | – | 0.05% | 113 |
|
|
2020
Q2 | $412K | Buy |
2,512
+8
| +0.3% | +$1.23K | 0.06% | 99 |
|
|
2020
Q1 | $347K | Sell |
2,504
-204
| -8% | -$28K | 0.06% | 101 |
|
|
2019
Q4 | $356K | Buy |
2,708
+204
| +8% | +$23.6K | 0.06% | 107 |
|
|
2019
Q3 | $280K | Sell |
2,504
-234
| -9% | -$26.1K | 0.05% | 115 |
|
|
2019
Q2 | $303K | Sell |
2,738
-386
| -12% | -$45.5K | 0.05% | 113 |
|
|
2019
Q1 | $405K | Buy |
3,124
+11
| +0.4% | +$1.34K | 0.08% | 95 |
|
|
2018
Q4 | $360K | Sell |
3,113
-53
| -2% | -$5.92K | 0.07% | 99 |
|
|
2018
Q3 | $340K | Buy |
+3,166
| New | +$317K | 0.07% | 109 |
|
|
2017
Q4 | – | Sell |
-2,395
| Closed | -$205K | – | 59 |
|
|
2017
Q3 | $205K | Buy |
+2,395
| New | +$196K | 0.05% | 108 |
|
|
2016
Q3 | – | Sell |
-2,731
| Closed | -$215K | – | 97 |
|
|
2016
Q2 | $215K | Buy |
+2,731
| New | +$206K | 0.07% | 88 |
|
Other funds holding LLY
Pure Financial Advisors's LLY Position: Q2 2026 in Review
Pure Financial Advisors increased its Eli Lilly (LLY) stake by 41% in Q2 2026, buying an estimated $2.07M and bringing the position to 7,010 shares worth $8.41M. The position accounts for 0.11% of the portfolio, ranked #90.
Pure Financial Advisors first reported a position in LLY in Q2 2016 and has held it in 34 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Pure Financial Advisors held 7,010 shares of Eli Lilly worth $8.41M as of Q2 2026.
- Pure Financial Advisors bought 2,026 Eli Lilly shares in Q2 2026, an estimated $2.07M.
- Eli Lilly made up 0.11% of Pure Financial Advisors's portfolio in Q2 2026, its #90 holding.
- Pure Financial Advisors first reported a position in Eli Lilly in Q2 2016 and has held it in 34 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.